|Articles|September 1, 2012
- BioPharm International-09-01-2013
- Volume 26
- Issue 9
BioPharm International, September 2012 Issue (PDF)
Trends in BioPharma
Advertisement
Articles in this issue
about 12 years ago
Trends in Downstream Bioprocessingabout 12 years ago
Identification and Quantification of Trace-Level Protein Impuritiesabout 12 years ago
Report from Brazilabout 12 years ago
Regulatory Roundupabout 12 years ago
Gauging the Outlook of the Biologics Marketabout 12 years ago
The Elements of Trainingabout 12 years ago
Prefilter Features PES Nanofleece Materialabout 12 years ago
Ion Exchange Chromatography Resins for High-Resolution Purificationabout 12 years ago
EU Raises API Standards: A Curse in Disguise?about 12 years ago
Best Practices for Restricted Access Barrier SystemsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Everything to Know About Cell and Gene Therapy in 2025
2
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
3
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
4
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
5
